Organigram (OGI) Global announced the expansion of its international product portfolio, with the launch of Edison and BOXHOT medical cannabis vape and pastille products in Australia. Organigram already supplies indoor-grown flower to the Australian market through existing B2B supply relationships. With this expansion, the company is introducing 10 product SKUs in Australia across its Edison and BOXHOT brands.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OGI:
- Organigram Global Moves to Acquire Stake in Germany’s Sanity Group, Expanding European Cannabis Reach
- Organigram price target raised to C$4 from C$3 at Canaccord
- Organigram Secures C$65.2 Million BAT Investment to Back Sanity Group Deal
- Organigram announces C$65.2M BAT private placement investment
- Organigram to Acquire Germany’s Sanity Group in Major European Cannabis Push